An article written by Jonathan Roses and Matthew Birkett, partner at Hoffmann Eitle, titled "Double Patenting in the USA and Europe" was published in The Pharma Letter. Read more (subscription required).
This article is the second in a series exploring legal issues relevant to the life sciences industry and how they vary between the two major jurisdictions of the United States and Europe. The other articles included in this series are:
